Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis
Clinical trial NCT05163886 · COMPLETED
Trial details
- NCT number
- NCT05163886
- Sponsor
- OrphAI Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-23
- Primary completion
- 2023-01-11
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.